Badge Close Icon
NEWS -
Aliquetin phasellus feugiat lobortis tortor hendrerit ultricies mus aliquam malesuada
Badge Close Icon

105. A First Insight into the Developability of an Immunoglobulin G3: A Combined Computational and Experimental Approach

105. A First Insight into the Developability of an Immunoglobulin G3: A Combined Computational and Experimental Approach
No items found.

Conference

Abstract

Immunoglobulin G 3 (IgG3) monoclonal antibodies (mAbs) are high-value scaffolds for developing novel therapies. Despite their wide-ranging therapeutic potential, IgG3 physicochemical properties and developability characteristics remain largely under-characterized. Protein–protein interactions elevate solution viscosity in high-concentration formulations, impacting physicochemical stability, manufacturability, and the injectability of mAbs. Therefore, in this manuscript, the key molecular descriptors and biophysical properties of a model anti-IL-8 IgG1 and its IgG3 ortholog are characterized. A computational and experimental framework was applied to measure molecular descriptors impacting their downstream developability. Findings from this approach underpin a detailed understanding of the molecular characteristics of IgG3 mAbs as potential therapeutic entities. This work is the first report examining the manufacturability of IgG3 for high-concentration mAb formulations. While poorer conformational and colloidal stability and elevated solution viscosity were observed for IgG3, future efforts controlling surface potential through sequence-engineering of solvent-accessible patches can be used to improve biophysical parameters that dictate mAb developability.

Publication description

Link to publication

https://doi.org/10.1021/acsptsci.4c00271